These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3054277)

  • 1. [Have angiotensin-converting enzyme inhibitors improved therapy of hypertension?].
    Rahn KH
    Klin Wochenschr; 1988 Sep; 66(18):920-3. PubMed ID: 3054277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.
    Suliburska J; Skrypnik K; Szulińska M; Kupsz J; Markuszewski L; Bogdański P
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30208601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients.
    Dessì-Fulgheri P; Espinosa E; Zingaretti O; Guazzarotti F; Sarzani R; Pupita G; Sturbini S; Catalini R; Rappelli A
    J Hypertens; 1993 Jul; 11(7):725-30. PubMed ID: 8228191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M
    Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists combined with beta-blockers or ACE inhibitors in the treatment of hypertension.
    Dahlöf B; Eggertsen R; Hansson L
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S104-8. PubMed ID: 2468890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant Hypertension: Which Agent?
    Prosser HCG; Azzam O; Schlaich MP
    Heart Lung Circ; 2018 Aug; 27(8):911-916. PubMed ID: 29526418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angiotensin-converting enzyme inhibitors and calcium antagonists in the treatment of mild to moderate systemic hypertension, according to baseline ambulatory blood pressure level.
    Herpin D; Vaisse B; Pitiot M; de Gaudemaris R; Mallion JM; Poggi L; Demange J
    Am J Cardiol; 1992 Apr; 69(9):923-6. PubMed ID: 1550022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics.
    Sinaiko AR
    J Hum Hypertens; 1994 May; 8(5):389-94. PubMed ID: 8064788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertension.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(10):17C-25C. PubMed ID: 1546635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.